FY2021 EPS Estimates for Endo International plc – (ENDP) Increased by Analyst

Posted by Joseph Casey on Apr 22nd, 2017

Endo International plc – (NASDAQ:ENDP) – Research analysts at Gabelli upped their FY2021 earnings per share estimates for Endo International plc – in a research note issued on Thursday, according to Zacks Investment Research. Gabelli analyst K. Kedra now anticipates that the company will earn $4.70 per share for the year, up from their prior estimate of $4.65.

Other analysts also recently issued reports about the company. William Blair restated a “market perform” rating on shares of Endo International plc – in a report on Saturday, March 11th. Guggenheim restated a “buy” rating and set a $35.00 price objective on shares of Endo International plc – in a report on Tuesday, February 28th. JPMorgan Chase & Co. downgraded Endo International plc – from an “overweight” rating to a “neutral” rating and set a $20.00 price objective for the company. in a report on Friday, January 20th. Citigroup Inc downgraded Endo International plc – from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $25.00 to $20.00 in a report on Thursday, January 5th. Finally, Piper Jaffray Companies set a $12.00 price objective on Endo International plc – and gave the stock a “hold” rating in a report on Friday, January 27th. Thirteen analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $20.72.

Earnings History and Estimates for Endo International plc - (NASDAQ:ENDP)

TRADEMARK VIOLATION WARNING: This report was originally published by Transcript Daily and is owned by of Transcript Daily. If you are reading this report on another site, it was illegally stolen and republished in violation of United States and international copyright laws. The original version of this report can be read at https://transcriptdaily.com/2017/04/22/fy2021-eps-estimates-for-endo-international-plc-endp-increased-by-analyst.html.

Endo International plc – (NASDAQ:ENDP) traded down 1.81% during midday trading on Friday, hitting $10.29. The company had a trading volume of 5,835,433 shares. The stock’s 50-day moving average price is $10.78 and its 200-day moving average price is $14.57. The stock’s market cap is $2.29 billion. Endo International plc – has a 52-week low of $9.70 and a 52-week high of $33.25.

Endo International plc – (NASDAQ:ENDP) last announced its earnings results on Tuesday, February 28th. The company reported $1.77 EPS for the quarter, beating analysts’ consensus estimates of $1.63 by $0.14. Endo International plc – had a positive return on equity of 15.95% and a negative net margin of 3.32%. The business earned $1.24 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter in the prior year, the firm earned $1.36 earnings per share. The business’s revenue was up 15.6% compared to the same quarter last year.

In other news, Director Nancy J. Hutson sold 5,325 shares of the stock in a transaction dated Thursday, March 9th. The shares were sold at an average price of $10.82, for a total transaction of $57,616.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.70% of the company’s stock.

Institutional investors have recently modified their holdings of the company. State Street Corp boosted its position in shares of Endo International plc – by 5.3% in the fourth quarter. State Street Corp now owns 9,642,033 shares of the company’s stock valued at $158,792,000 after buying an additional 483,271 shares during the last quarter. Systematic Financial Management LP bought a new position in shares of Endo International plc – during the fourth quarter valued at approximately $43,256,000. Norges Bank bought a new position in shares of Endo International plc – during the fourth quarter valued at approximately $26,929,000. TIAA CREF Investment Management LLC boosted its position in shares of Endo International plc – by 27.4% in the third quarter. TIAA CREF Investment Management LLC now owns 955,182 shares of the company’s stock valued at $19,247,000 after buying an additional 205,522 shares during the last quarter. Finally, Teachers Advisors LLC boosted its position in shares of Endo International plc – by 8.2% in the third quarter. Teachers Advisors LLC now owns 915,716 shares of the company’s stock valued at $18,452,000 after buying an additional 69,313 shares during the last quarter. 95.50% of the stock is currently owned by institutional investors and hedge funds.

About Endo International plc –

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.